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Abstract
Background: The use of ambulatory blood pressure monitoring (ABPM) in the diagnosis and
management of hypertension in primary care settings in the United States is increasing. Insufficient
information is available describing patients' experiences and acceptance of this technology in the
United States, where medical insurance coverage of the procedure is often limited. The objective
of this study was to describe patient satisfaction with ABPM performed in a primary care office in
the United States, using modern ABPM technology.
Methods:  Cross-sectional survey performed on consecutive patients referred to the ABPM
service of the Family Care Center, University of Iowa Hospitals and Clinics, Iowa City, Iowa from
January 2001 to July 2003. Measures of patient satisfaction and acceptance with the device, comfort,
and overall session were assessed via a 9-question, Likert-scale response survey.
Results: Since its inception two and a half years ago, 245 total ABPM sessions have been conducted
in 235 unique patients. Of the 235 eligible respondents, 177 returned completed surveys, yielding
a 75% response rate. Three-fourths (75%) of patients believed that undergoing the test was
worthwhile considering the time and monetary cost involved, while most (90%) reported they
thought the information provided by the test would be helpful to their physician in making
treatment decisions. Patients reporting that their physician had clearly explained the benefit of
undergoing the testing were more likely to report that they thought the results of the test would
be more helpful in making treatment decisions. Few patients (20%) found that wearing the monitor
was uncomfortable.
Conclusions: When clinically indicated, clinicians should not hesitate to order ABPM testing for
fear of subjecting patients to an uncomfortable test, or an uncovered insurance benefit. When
ordering ABPM, they should be sure to educate the patient about the potential benefits of
undergoing the testing. Most patients believe the test will provide useful information in making
treatment decisions, despite probable lack of insurance coverage, and appear willing to experience
some discomfort for the overall gain of the results obtained from undergoing the session.
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Background
Non-invasive, 24-hour ambulatory blood pressure moni-
toring (ABPM) has emerged as an important instrument
assisting clinicians in the diagnosis and management of
hypertension. Although several studies have validated the
prognostic significance of data acquired from ABPM; his-
torically, access to the technology in the United States is
generally limited to specialty referral clinics such as cardi-
ology or nephrology, found in larger teaching institutions
[1–4]. The limited access in primary care offices is proba-
bly due, in part, to the lack of reimbursement by most
medical insurance companies for the procedure. Thus, the
routine use of the technology in primary-care offices is
somewhat of a novelty.
However, the landscape of ABPM in the United States is
currently shifting. Recent prospective outcome studies
have fueled the argument that ABPM should play a more
prominent role in the diagnosis and management of the
hypertensive patient [5]. The Joint National Committee of
the National High Blood Pressure Education Program and
the British Hypertension Society recommend its use in a
number of clinical scenarios, while other organizations
have cautiously endorsed its use [6–11]. Although some
experts question the cost-effectiveness of routine use of
ABPM in hypertensive patients [12], others have pro-
claimed that judicious ABPM use can actually decrease
cost of care [13,14]. When available, ABPM appears to be
well-accepted by physicians [15].
With recent accumulating evidence supporting the role of
ABPM in clinical practice, the United States Centers for
Medicare and Medicaid Services (CMS) now reimburses
for the testing in patients with suspected white-coat hyper-
tension [16]. Because a significant number of patients
with hypertension are insured by Medicare, it is likely that
the demand for ABPM services will increase, and this shift
will occur in primary care clinics [17]. Several prior studies
have examined utilization of ABPM in clinical practice;
that is, reasons why physicians order the test and how the
results of the test influence decision-making [18–20].
While these studies have documented the physician use
and acceptance of ABPM technology, none of the studies
examined patient satisfaction associated with use of
ABPM in this setting. Furthermore, improved microelec-
tronic and battery technology have allowed the equip-
ment to become more compact and lightweight in the last
10 years, increasing portability and perhaps comfort.
Patients undergoing ABPM testing are required to wear the
device for 24-hours, during which time the monitor
records blood pressure at regularly programmed intervals
[17]. Since patients are asked to go about their normal
daily activities while wearing the monitor, it is probable
they will experience some discomfort during the session
and anticipation of this discomfort may negatively influ-
ence their acceptance of undergoing the testing, and pos-
sibly their acceptance of any pharmacologic interventions
which might result from the testing. Because limited infor-
mation exists in the medical literature on this topic, and
particularly lacking in the primary care setting, the pur-
pose of this report is to describe our primary care clinic's
experience with patient acceptance of ABPM.
Methods
Description of the ABPM Service
The ABPM service is located within the University of Iowa
Family Care Center. The Family Care Center serves nearly
60,000 patient visits yearly between its Family Medicine
and Internal Medicine outpatient clinics. The ABPM serv-
ice is co-directed by a board-certified family physician
(GB) and a clinical pharmacist who is a board-certified
pharmacotherapy specialist (ME).
Primary care physicians who, in the course of a routine
office visit determine that ABPM is clinically indicated in
the management of their patient, refer the patient to the
service. The patient returns to the clinic on a different day
to have the monitor fitted by the clinical pharmacist, and
returns the monitor the next day after completing the 24-
hour testing period. The data from the monitor is then
downloaded into a software program for data analysis.
The report is initially reviewed by the clinical pharmacist,
with particular reference to the effects of any medications,
then the results are forwarded to the ordering physician
for final review and action.
SpaceLabs Medical, Inc. (Redmond, WA) 90207 Ultralite
ABP monitors are used by the service. The computer soft-
ware program used is the ABP Report Management Sys-
tem, version 1.03.11 from SpaceLabs Medical, Inc., which
provides a printout of all blood pressures, including sum-
mary statistics for mean blood pressures and blood pres-
sure load for daytime, nighttime and overall 24 hours. The
service began in January 2001 and follow-up for this study
represents data accrued through July 31, 2003. The study
was approved by the University of Iowa institutional
review board.
Patient Satisfaction Survey
Consecutive patients referred for ABPM testing by their
primary care provider were asked to complete a 9-item
questionnaire regarding their experience with ABPM,
upon completion of the 24-hour ABPM session (see Addi-
tional File 1). The questionnaire was anonymous and if
patients did not return the survey, they were not contacted
with a follow-up reminder. Patients who were referred for
a follow-up ABPM session were only surveyed once.BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/15
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The questionnaire asked for responses to the following
questions regarding the ABPM session, using a five point
Likert scale ranging from "strongly agree" to "strongly dis-
agree": "My doctor clearly explained the benefit of undergoing
this testing;" "Wearing the monitor for 24 hours was not
uncomfortable;" "Considering the monetary and time cost to
me, I think undergoing ambulatory blood pressure monitoring
was worthwhile;" "I think information provided by the test will
be helpful in making decisions about how to treat my blood
pressure;" and, "Overall, I am very satisfied with my experi-
ence." The other four questions on the survey asked specif-
ically about the physical resources of the ABPM service,
such as location and staff involved, and were included for
quality assurance purposes. Thus, their responses are not
relevant to this analysis. Finally, space was given on the
survey for any additional comments patients wished to
include. These comments were aggregated into major
themes.
The data obtained from the survey were entered into a
spreadsheet and frequency distributions and descriptive
statistics were used to summarize the data. For analysis
purposes, responses of "neutral" were considered to be a
negative response and grouped with the "disagree" and
"strongly disagree" responses as a more conservative
method of assessing satisfaction, while "strongly agree"
and "agree" responses were combined. Comparisons
between the groupings were assessed via chi-square
analysis.
Results
Two hundred forty-five ABPM sessions were performed
between January 1, 2001 and July 31, 2003. Ten patients
had two or more ABPM sessions during this period, reduc-
ing the number of eligible participants surveyed to 235.
Of these, 177 returned patient satisfaction surveys yield-
ing a final response rate of 75%.
Because the survey was anonymous, the demographic
data represent the demographics of the 245 patients who
completed at least one ABPM session, not just the
responders to the survey. The mean age of the ABPM par-
ticipants was 52.6 years (range 17–86; std. dev 16.3), and
just over half (51%) of the patients were male (Table 1).
While Family Medicine physicians ordered more of the
ABPM sessions (n = 137/245; 56%) than Internal Medi-
cine physicians, the indications for ordering the test were
not different between the two groups (chi-square, p =
0.13).
The most frequent indication (n = 71; 29% of patients) for
undergoing ABPM testing was to evaluate blood pressure
control on current antihypertensive therapy, followed by
evaluation of borderline office hypertension (n = 62; 25%
of patients), and suspected white-coat hypertension in an
untreated patient (n = 60; 24% of patients). The most
common management outcome resulting from the data
obtained from the ABPM test was the initiation of an
antihypertensive agent (n = 51; 21% of patients). White-
coat hypertension was diagnosed in 20% of the patients.
Overall, the ABPM sessions were well-tolerated, with only
3 patients failing to wear the device for the entire testing
period. Complications, such as petichiae at the cuff site, or
arm thrombosis, were not reported by any of the patients.
Patient satisfaction was generally high with ABPM in this
setting. Of the 177 surveys returned, 75% (n = 132/177)
of patients reported that the twenty-four hour ABPM test
was worthwhile when considering the time and monetary
cost of the session. Most patients (n = 132/177; 90%)
thought the test results would provide information that
would help their physician make treatment decisions.
Overall, most patients (n = 157/177; 89%) reported being
satisfied with their ABPM experience.
Despite the overall positive patient perceptions of ABPM,
some patients voiced dissatisfaction with the comfort of
ABPM. Twenty percent (n = 36/177) of patients reported
that the ABPM session was uncomfortable, while another
28% (n = 50/177) responded neutrally to the statement.
However, when asked about whether the test results
would provide useful information in helping make treat-
ment decisions, the 86 patients who rated ABPM as
uncomfortable or neutral were just as likely to report that
they believed the test would provide useful information to
help make treatment decisions, as the 89 patients who
reported no discomfort from the test (chi-square; p =
0.07).
A second area of dissatisfaction reported by patients was
related to whether their physician clearly explained the
benefit of undergoing the testing. Seventeen (7%) patients
did not feel that their physician had clearly explained the
benefit of undergoing the testing. Additionally, 30% of
these patients reported they did not think the results of
the ABPM testing would be helpful in making treatment
decisions. In contrast, of the 159 (90%) patients who
reported that their physician had clearly explained the
benefit of undergoing the testing, only 6% reported they
did not think the results of the test would be helpful (chi-
square; p < 0.01). Further analysisofthe patients who
reported that their physician did not clearly explain the
benefit of the testingfound a trend forreporting greater
discomfort with the test (chi-square; p = 0.11)compared
to patients who reported they were satisfied with their
physicians' explanations of the benefit of undergoing the
testing.
Finally, in the open ended general comment section, 43
patients provided content which were organized into 4BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/15
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general themes: (1) problems with the ABPM session
(e.g., physical discomfort; difficulty performing normal
daily activities; difficulty sleeping); (2) perceived benefit
of undergoing the testing (e.g. unsure what useful infor-
mation would be obtained) (3) ease of testing (e.g. sur-
prised at how easy the test was); and, (4) miscellaneous
(e.g. scheduling, fitting of monitor, etc.). The most com-
mon written comment, mentioned by 24 patients, per-
tained to the ABPM device and problems encountered
while performing activities of daily living and sleep. How-
ever, 9 patients noted the test was easier than expected and
that the information should be helpful in making treat-
ment decisions.
Discussion
Over a two-and-a-half-year period, patients undergoing
ABPM in a primary care office setting in the United States
reported that this method of testing was well-accepted
and tolerated. The most common complaint was about
discomfort while undergoing the testing but only 20% of
patients reported this trouble. Additionally, even those
patients who offered this complaint generally felt the test
was worthwhile.
Although ABPM recordings are considered more reliable
than office or home blood pressure measurements, there
is a trade-off between patient comfort and accuracy with
ABPM. Our data indicate that patients generally believe
the results will be helpful in making treatment decisions
and are willing to be inconvenienced by an ABPM session.
We also found that thephysician's effectiveness in explain-
ing the need for ABPM testingto a patientis linked to the
patients' perception of the study. Thus, physicians should
clearly explain the benefit of undergoing ABPM testing to
their patients when it is ordered.
Our findings about patient satisfaction with ABPM are the
first reported in a population from the United States, a
country where ABPM is generally not reimbursed, and
routine use of ABPM in clinical practice is the exception
and not the norm. Our results are consistent with those
described in a recent qualitative study of ABPM in Great
Britain [21]. In this study, patient preferences for different
methods of measuring blood pressure (home, ambula-
tory, nurse, doctor) in the primary care setting were com-
pared, and it was concluded that respondents felt all
methods were worth the trouble to get accurate measure-
ments [21]. However, home blood pressure monitoring
has limitations which include lack of recording during
sleep hours, an important time period for obtaining data
which may have value for prognosis, as well as questiona-
ble accuracy as patients may not record their blood pres-
sures faithfully [22,23]. Although ambulatory
measurements were noted in the study findings to have
higher likelihood of discomfort and disturbance of life
and sleep compared to the other methods of measure-
ment, it was otherwise well-accepted by patients. Our
findings are fairly similar; this similar level of acceptance
is notable given the differencesinuse of ABPM and how
Table 1: Demographics of the population undergoing ABPM testing one or more times during the analysis period (n = 245).
Age (in years)
Mean ± SD 52.6 ± 16.3
(Range) (17–86)
Gender
Female 119 (49%)
Male 126 (51%)
Indication for ABPMa
Evaluation of blood pressure control 71 (29%)
Borderline hypertensionb 62 (25%)
Suspected white-coat hypertension 60 (24%)
Treatment resistance 19 (8%)
Other 33 (13%)
Outcome Resulting from ABPMa
Medication initiated 51 (21%)
Diagnosed white-coat hypertension 49 (20%)
No change in therapy (blood pressure controlled) 37 (15%)
Medication changed 31 (13%)
Dose/regimen adjusted 21 (9%)
Recommend lifestyle modifications 14 (6%)
Other/unknown 42 (18%)
a categories are mutually exclusive b defined as those patients with office blood pressures that are elevated into the Stage 1 range at some visits, but 
also in the pre-hypertension range (per JNC-VII classification – ref. [10]) at other visits. These patients are untreated and have not been officially 
diagnosed with hypertension.BMC Family Practice 2003, 4 http://www.biomedcentral.com/1471-2296/4/15
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medical care is financedin Great Britain compared to the
United States.
Aside from the study by Little et al. [21], there is a modest
amount of other information about patient satisfaction
with ABPM. Acceptability and tolerance of ABPM was
evaluated in a study by Mallion et al. based on a case series
of 672 patients [24]. Problems that patients encountered
while undergoing ABPM included those related to the cuff
pressure (32%), awkwardness of the machine (14%) and
noise of the monitor (6%). Sleep disturbances were
reported by 55% of patients, although only 14% of
patients reported more than 3 awakenings. However, this
study differed from ours and could be subject to bias since
the physician ordering the test actually filled out the sur-
vey after asking the patient a series of questions upon
completing the ABPM session. Furthermore, the study was
performed in French cardiologist offices using older
ABPM equipment. Thus, it unlikely that these findings
apply to a primary care population in the United States
undergoing ABPM using current technology.
Our study must be interpreted within the context of sev-
eral important limitations. The demographics reported
represent the entire population completing ABPM, not
just the survey responders; thus, no information is known
about survey non-reponders and how their experience
with ABPM compared. However, our response rate was
very high, which increases the generalizability of our data
and suggests we have accurately assessed the perceptions
of patients undergoing ABPM within our setting. Sec-
ondly, our study was conducted at one site, so geographi-
cal differences in practice styles might be a consideration.
However, our site is a typical primary care setting in the
United States, and to our knowledge the study is the first
to examine patient satisfaction with ABPM in this setting.
This is important since ABPM is likely to transition from
being used almost exclusively in specialty referral clinics
to more widespread use in primary care settings. Lastly, it
is known that physician approach can often influence
patient behavior. We did not provide suggested language
to physicians for how to explain to the patient the ration-
ale and need for ordering the test. It is possible that con-
fusion on the part of the uninformed patient might then
have influenced survey responses, although our study
reflects how the test would likely be ordered in usual
practice.
In spite of these limitations, our survey provides useful
information regarding patient acceptance of modern
ABPM testing in a primary care setting in the United
States. Because of its proven utility in the clinical setting,
and recent CMS approval for coverage in patients with
suspected white coat hypertension, demand for the ABPM
testing in the future is likely to shift predominantly from
specialty referral centers to primary care offices.
Conclusions
When clinically appropriate, clinicians should not hesi-
tate to order ABPM for fear of subjecting their patient to
potential discomfort, and they should be sure to educate
the patient about the potential benefits of undergoing the
testing. Despite in many cases being an uncovered insur-
ance benefit, patients generally believe the test will pro-
vide useful information in making treatment decisions,
and appear willing to experience some discomfort in the
process.
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